Human intelligence and technology united to re-engineer drug discovery and deliver life-changing medicines.
Our expanding biomedical knowledge base of contextualised machine-curated relationships and proprietary insights represents what is known and can be inferred about a disease.
Data-driven Target ID built on our machine learning models selects and validates the highest quality, hypotheses for novel drug targets.
At Benevolent we build technology in the service of science - to augment human intelligence and inspire the discovery of new medicines for the thousands of diseases that have no treatment.
"The fragile nature of life and health has never been more apparent, but the partnership of human and artificial intelligence promises to accelerate new discoveries, new therapies and new hope for patients."